Contemporary use of devices in heart failure

Clinical Pharmacology and Therapeutics

Volumn 94, Issue 4, 2013, Pages 433-435

  Maass, A H ^a   Van Veldhuisen, D J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR;

BLOOD PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; COMPLETE HEART BLOCK; CONVULSIVE THERAPY; CORONARY SINUS; COST EFFECTIVENESS ANALYSIS; DEVICE THERAPY; GENE EXPRESSION; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; HYPERVOLEMIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; LIFE EXPECTANCY; LUNG ARTERY PRESSURE; NONISCHEMIC CARDIOMYOPATHY; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTORY PERIOD; REVIEW; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC DYSFUNCTION; THERAPY EFFECT; TREATMENT FAILURE; VAGUS NERVE STIMULATION;

CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS;

EID: 84884491333     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.144     Document Type: Review

References (10)

1. Abraham, W.T. et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377, 658-666 (2011).
2. Olde Nordkamp, L.R. et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J. Am. Coll. Cardiol. 60, 1933-1939 (2012).
3. Borggrefe, M. & Burkhoff, D. Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. Eur. J. Heart Fail. 14, 703-712 (2012).
4. Laurent, G. et al. Permanent left atrial pacing therapy may improve symptoms in heart failure patients with preserved ejection fraction and atrial dyssynchrony: a pilot study prior to a national clinical research programme. Eur. J. Heart Fail. 15, 85-93 (2013).
5. Chung, E.S. et al. Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction 35%: a PROSPECT trial substudy. Eur. J. Heart Fail. 12, 581-587 (2010).
6. Curtis, A.B. et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N. Engl. J. Med. 368, 1585-1593 (2013).
7. McMurray, J.J. et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 14, 803-869 (2012).
8. van Veldhuisen, D.J. et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur. J. Heart Fail. 11, 1143-1151 (2009).
9. Park, S.J., Kushwaha, S.S. & McGregor, C.G. State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy. Clin. Pharmacol. Ther. 91, 94-100 (2012).
10. van Veldhuisen, D.J. et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124, 1719-1726 (2011).